Reuters logo
BRIEF-Oramed receives approval for clinical study to treat NASH
November 14, 2017 / 1:15 PM / 9 days ago

BRIEF-Oramed receives approval for clinical study to treat NASH

Nov 14 (Reuters) - Oramed Pharmaceuticals Inc

* Oramed receives regulatory approval to conduct clinical study for treatment of NASH with its oral insulin capsule

* Israel’s ministry of health granted company approval to initiate exploratory clinical study of ORMD-0801 in patients with NASH​

* Proposed study will assess effectiveness of ORMD-0801 in reducing liver fat content, inflammation and fibrosis in patients with NASH​

* Says ‍plans on initiating study in coming month​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below